AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16038599 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine monotherapy
Number of subjects: 0
Study 16038599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11977509 — intervention group
Group type: EXPERIMENTAL
Intervention: Shu Feng Huo Luo Pian, 2 pills, p.o., bid, supplemented with calcium Caltrate D 0.6 g, p.o., qd for 2 courses (2 weeks each)
Number of subjects: 50
Study 11977509 — intervention group
Group type: COMPARATOR
Intervention: Sulindac 0.2 g, p.o., bid, supplemented with calcium Caltrate D 0.6 g, p.o., qd for 2 courses (2 weeks each)
Number of subjects: 50
Study 10067800 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (20 to 40-80 mg once a day)
Number of subjects: 278
Study 10067800 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 to 10-20 mg once a day)
Number of subjects: 278
Study 10067800 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 278
Study 10067800 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 278
Study 7669484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40‐5967 (50 mg daily)
Number of subjects: 42
Study 7669484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40‐5967 (100 mg daily)
Number of subjects: 42
Study 7669484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40‐5967 (150 mg daily)
Number of subjects: 42
Study 7669484 — intervention group
Group type: COMPARATOR
Intervention: Digoxin alone (0.375 mg daily)
Number of subjects: 42
Study 2149048 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 44
Study 2149048 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study 312486 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 0
Study 312486 — intervention group
Group type: EXPERIMENTAL
Intervention: Kanamycin
Number of subjects: 0
Study 312486 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 0
Study 30689549 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 58
Study 30689549 — intervention group
Group type: COMPARATOR
Intervention: Sham-RIC (Control)
Number of subjects: 58
Study 28965718 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-TT
Number of subjects: 112
Study 28965718 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-PS
Number of subjects: 112
Study 28965718 — intervention group
Group type: COMPARATOR
Intervention: Control (Meningococcal vaccine)
Number of subjects: 112
Study 26503021 — intervention group
Group type: EXPERIMENTAL
Intervention: Early AED withdrawal starting 4 months after surgery, with intended complete cessation of drugs after 12 months.
Number of subjects: 180
Study 26503021 — intervention group
Group type: COMPARATOR
Intervention: Late AED withdrawal starting 12 months after surgery, with intended complete cessation of drugs after 20 months.
Number of subjects: 180
Study 23504186 — intervention group
Group type: EXPERIMENTAL
Intervention: Alg1 (AV and VV optimization)
Number of subjects: 80
Study 23504186 — intervention group
Group type: COMPARATOR
Intervention: Standard commercial procedures (control)
Number of subjects: 80
Study 21039927 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilpaterol-HCl (60 mg/day)
Number of subjects: 12
Study 21039927 — intervention group
Group type: COMPARATOR
Intervention: Control (no zilpaterol)
Number of subjects: 12
Study 19657121 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 78
Study 19657121 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham procedure)
Number of subjects: 78
Study 17545078 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hemocoagulase acutus at 1 U
Number of subjects: 45
Study 17545078 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hemocoagulase acutus at 2 U
Number of subjects: 45
Study 17545078 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 45
Study 11061989 — intervention group
Group type: EXPERIMENTAL
Intervention: 260 mg/d ascorbate
Number of subjects: 20
Study 11061989 — intervention group
Group type: EXPERIMENTAL
Intervention: 260 mg/d ascorbate plus 14 mg/d iron
Number of subjects: 20
Study 11061989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8825843 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental presence during lumbar puncture (LP)
Number of subjects: 57
Study 8825843 — intervention group
Group type: COMPARATOR
Intervention: Control group (parents remaining outside during LP)
Number of subjects: 57
Study 1449564 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol, 1 g/kg within 1 hr
Number of subjects: 0
Study 1449564 — intervention group
Group type: COMPARATOR
Intervention: Juice
Number of subjects: 0
Study 1449564 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 0
Study 2578421 — intervention group
Group type: EXPERIMENTAL
Intervention: 28-day cycle of adenine arabinoside 5' monophosphate (ARA-AMP)
Number of subjects: 38
Study 2578421 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 28-day cycles of ARA-AMP separated by a 4-wk rest interval
Number of subjects: 38
Study 2578421 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of prednisone therapy followed by 28 days of ARA-AMP therapy
Number of subjects: 38
Study 30915660 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab (100 mg dose)
Number of subjects: 2098
Study 30915660 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 2098
Study 30915660 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with increased body weight
Number of subjects: 2098
Study 30580268 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation programme (supervised exercise, psychological coaching, nutritional support)
Number of subjects: 0
Study 30580268 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 30580268 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation programme
Number of subjects: 0
Study 27103030 — intervention group
Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 86
Study 27103030 — intervention group
Group type: COMPARATOR
Intervention: GlideScope®
Number of subjects: 86
Study 27103030 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq®
Number of subjects: 86
Study 27103030 — intervention group
Group type: EXPERIMENTAL
Intervention: King Vision™
Number of subjects: 86
Study 24114551 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized text messaging intervention (4-6 messages daily for 4 days)
Number of subjects: 18
Study 24114551 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized text messaging intervention
Number of subjects: 18
Study 21923756 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 98
Study 21923756 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 98
Study 19962118 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week online intervention
Number of subjects: 170
Study 19962118 — intervention group
Group type: COMPARATOR
Intervention: 6-week weight and caloric feedback only (via email)
Number of subjects: 170
Study 19962118 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week combined feedback and online intervention
Number of subjects: 170
Study 19962118 — intervention group
Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 170
Study 18550345 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine full dose (OFD)
Number of subjects: 97
Study 18550345 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine reduction dose (ORD)
Number of subjects: 97
Study 15758738 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin (BCG)
Number of subjects: 265
Study 15758738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 12819915 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital chest radiography combined with dual‐energy chest radiography
Number of subjects: 20
Study 12819915 — intervention group
Group type: COMPARATOR
Intervention: Digital chest radiography alone
Number of subjects: 20
Study 10355212 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain treatment
Number of subjects: 313
Study 10355212 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong opioids
Number of subjects: 313
Study 10355212 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics 'as needed'
Number of subjects: 313
Study 10355212 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' pain knowledge
Number of subjects: 313
Study 10355212 — intervention group
Group type: EXPERIMENTAL
Intervention: Written pain information
Number of subjects: 313
Study 10355212 — intervention group
Group type: EXPERIMENTAL
Intervention: District nurses informed about patients' pain
Number of subjects: 313
Study 8594426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous standard heparin
Number of subjects: 400
Study 8594426 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous low-molecular-weight heparin
Number of subjects: 400
Study 2022110 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 1168
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs published in JCP
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs published in JOP
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs published in JPR
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall RCTs in all journals
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: Methodology section adherence
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: Results section adherence
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion section adherence
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest modified CONSORT score
Number of subjects: 369
Study 31732102 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest modified CONSORT score
Number of subjects: 369
Study 29157121 — intervention group
Group type: EXPERIMENTAL
Intervention: Signed family physician reminder letter and standard reminder postcard
Number of subjects: 5638
Study 29157121 — intervention group
Group type: COMPARATOR
Intervention: Standard reminder postcard alone
Number of subjects: 5638
Study 27456835 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular disease (history of macroalbuminuria)
Number of subjects: 10624
Study 27456835 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular disease (retinal photocoagulation therapy)
Number of subjects: 10624
Study 27456835 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular disease
Number of subjects: 10624
Study 27456835 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrovascular disease
Number of subjects: 10624
Study 27456835 — intervention group
Group type: EXPERIMENTAL
Intervention: Major PAD (composite outcome)
Number of subjects: 10624
Study 25303507 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolite system (IS)
Number of subjects: 42
Study 25303507 — intervention group
Group type: COMPARATOR
Intervention: Rubber dam (RD)
Number of subjects: 42
Study 22707262 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of canola oil, soybean oil, or butter
Number of subjects: 29
Study 22707262 — intervention group
Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acid rich canola oil
Number of subjects: 29
Study 20701667 — intervention group
Group type: EXPERIMENTAL
Intervention: capsaicin
Number of subjects: 56
Study 20701667 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐lipoic acid
Number of subjects: 56
Study 20701667 — intervention group
Group type: EXPERIMENTAL
Intervention: lysozyme‐lactoperoxidase
Number of subjects: 56
Study 20701667 — intervention group
Group type: COMPARATOR
Intervention: boric acid
Number of subjects: 56
Study 18559163 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 5 days
Number of subjects: 298
Study 15722322 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12824969 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing at 12 months
Number of subjects: 1539
Study 12824969 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat semiannual cytology with referral to colposcopy at an ASCUS threshold
Number of subjects: 1539
Study 12824969 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining cytology and HPV testing
Number of subjects: 1539
Study 10585165 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute creatine loading (25 g per day for 4 days)
Number of subjects: 22
Study 10585165 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer-term creatine supplementation (5 g of creatine per day for 2 months)
Number of subjects: 22
Study 10585165 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 g per day for 2 months)
Number of subjects: 22
Study 8936571 — intervention group
Group type: EXPERIMENTAL
Intervention: PALS Skills Training
Number of subjects: 296
Study 8936571 — intervention group
Group type: COMPARATOR
Intervention: No Skills (Control)
Number of subjects: 296
Study 8936571 — intervention group
Group type: EXPERIMENTAL
Intervention: PALS Skills Training + Normative Education
Number of subjects: 296
Study 2015161 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper sulphate 20 mg daily (n = 13)
Number of subjects: 21
Study 2015161 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo (n = 8)
Number of subjects: 21
Study 6285318 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐OP 1.5 U/kg/15 min
Number of subjects: 16
Study 6285318 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐OP 3.0 U/kg/15 min
Number of subjects: 16
Study 6285318 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study 30408191 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid prototype (DA)
Number of subjects: 99
Study 30408191 — intervention group
Group type: COMPARATOR
Intervention: Standard care procedures
Number of subjects: 99
Study 28797260 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised Patients (SP) workshop with and without video feedback
Number of subjects: 108
Study 28797260 — intervention group
Group type: COMPARATOR
Intervention: Usual teaching comprising peer role play
Number of subjects: 108
Study 25669611 — intervention group
Group type: EXPERIMENTAL
Intervention: dezocine 0.1 mg/kg
Number of subjects: 114
Study 25669611 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl 1 μg/kg
Number of subjects: 114
Study 25669611 — intervention group
Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 114
Study 23302751 — intervention group
Group type: COMPARATOR
Intervention: Control (4 minutes of passive rest)
Number of subjects: 12
Study 23302751 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum voluntary isometric knee extension (3 repetitions of 3‐second isometric knee extension)
Number of subjects: 12
Study 23302751 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum voluntary isometric back squat (3 repetitions of 3‐second isometric squat)
Number of subjects: 12
Study 23302751 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic back squat (3 repetitions of back squats at 90% 1 repetition maximum)
Number of subjects: 12
Study 21500889 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol with distraction
Number of subjects: 159
Study 21500889 — intervention group
Group type: COMPARATOR
Intervention: Alcohol without distraction
Number of subjects: 159
Study 21500889 — intervention group
Group type: EXPERIMENTAL
Intervention: No-alcohol control with distraction
Number of subjects: 159
Study 21500889 — intervention group
Group type: COMPARATOR
Intervention: No-alcohol control without distraction
Number of subjects: 159
Study 19283309 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adjusting design
Number of subjects: 0
Study 19283309 — intervention group
Group type: COMPARATOR
Intervention: Permuted-block randomization
Number of subjects: 0
Study 19283309 — intervention group
Group type: COMPARATOR
Intervention: Minimization method
Number of subjects: 0
Study 17709293 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of diazepam
Number of subjects: 10
Study 17709293 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of lorazepam
Number of subjects: 10
Study 17709293 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of zolpidem
Number of subjects: 10
Study 17709293 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale for sedative effects
Number of subjects: 10
Study 16332662 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glucosinolate broccoli (super broccoli)
Number of subjects: 16
Study 16332662 — intervention group
Group type: COMPARATOR
Intervention: Standard broccoli
Number of subjects: 16
Study 16332662 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 16
Study 12417875 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (specific dosage and duration not mentioned)
Number of subjects: 0
Study 12417875 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution computed tomography of the chest
Number of subjects: 0
Study 12417875 — intervention group
Group type: EXPERIMENTAL
Intervention: IgE serum isotypic antibodies to A fumigatus
Number of subjects: 0
Study 9665601 — intervention group
Group type: EXPERIMENTAL
Intervention: Different levels of attention in an auditory experiment
Number of subjects: 0
Study 7808274 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive exposure to a novel mobile 1, 2, or 3 days later
Number of subjects: 0
Study 7808274 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive exposure to a novel mobile after the longest exposure delay
Number of subjects: 0
Study 7808274 — intervention group
Group type: EXPERIMENTAL
Intervention: Original mobile exposure after the longest delay
Number of subjects: 0
Study 2582638 — intervention group
Group type: EXPERIMENTAL
Intervention: Diathermy
Number of subjects: 0
Study 2582638 — intervention group
Group type: COMPARATOR
Intervention: Ligation
Number of subjects: 0
Study 805264 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone hydrochloride (24 mg/day)
Number of subjects: 36
Study 805264 — intervention group
Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate (800 mg/day)
Number of subjects: 36
Study 30935619 — intervention group
Group type: EXPERIMENTAL
Intervention: GentleWave
Number of subjects: 30
Study 30935619 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-vented needle
Number of subjects: 30
Study 30935619 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoVac
Number of subjects: 30
Study 29122087 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg/mL triamcinolone
Number of subjects: 90
Study 29122087 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg/mL triamcinolone
Number of subjects: 90
Study 29122087 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 90
Study 25827670 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 megadose supplementation (200,000 IU)
Number of subjects: 40
Study 25827670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 23161645 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg oral prednisone given daily for 10 days
Number of subjects: 81
Study 23161645 — intervention group
Group type: COMPARATOR
Intervention: 50 mg etanercept given subcutaneously at randomisation and 1 week later
Number of subjects: 81
Study 21810257 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber (25 g) plus rosuvastatin 40 mg
Number of subjects: 116
Study 21810257 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 40 mg alone
Number of subjects: 116
Study 21810257 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinvastatin 40 mg plus ezetimibe 10 mg plus fiber (25 g)
Number of subjects: 116
Study 21810257 — intervention group
Group type: COMPARATOR
Intervention: Sinvastatin 40 mg plus ezetimibe 10 mg
Number of subjects: 116
Study 19369367 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine intake of 5 mg x kg(‐1) x d(‐1)
Number of subjects: 5
Study 19369367 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine intake of 20 mg x kg(‐1) x d(‐1)
Number of subjects: 5
Study 19369367 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine intake of 35 mg x kg(‐1) x d(‐1)
Number of subjects: 5
Study 19369367 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine intake of 70 mg x kg(‐1) x d(‐1)
Number of subjects: 5
Study 19369367 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation periods of 8 h, 3 d, or 7 d
Number of subjects: 5
Study 16672739 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood sexual assault
Number of subjects: 0
Study 16672739 — intervention group
Group type: EXPERIMENTAL
Intervention: Family factors (including parental conflict resolution)
Number of subjects: 0
Study 15160250 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime application of the SIII appliance
Number of subjects: 0
Study 15160250 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent forces from the SIII appliance
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐blockers
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel antagonists
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrates
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium channel agonists
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitors of platelet aggregation
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypolipemic agents
Number of subjects: 0
Study 11806300 — intervention group
Group type: EXPERIMENTAL
Intervention: Converting enzyme inhibitors
Number of subjects: 0
Study 11806300 — intervention group
Group type: COMPARATOR
Intervention: Vitamins C, E and B
Number of subjects: 0
Study 11806300 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics against intra‐cellular germs
Number of subjects: 0